Gilead Sciences (NasdaqGS:GILD) has entered a definitive agreement to acquire Ouro Medicines, expanding into T cell engager ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results ...

Preclinical data demonstrate deep and durable tumor regressions with lead product candidate ERNA-101 in combination with PD-1 Blockade in ovarian ...

The Japanese Ministry of Defense has announced that the JS Chōkai (DDG-176) has completed crew training and ship modification ...

First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

Oric Pharmaceuticals (NASDAQ:ORIC) detailed new dose-optimization results for its PRC2 inhibitor rinzimetostat and outlined ...

A sheriff's deputy allegedly found two small white pills in Tiger Woods' pants pocket, which were later identified as ...

T1 Energy Inc. ( TE) Q4 2025 Earnings Call March 31, 2026 8:00 AM EDT ...

Maine’s budget committee added a tax on millionaires to its plan, which could prompt a notable departure for Gov. Janet Mills ...

Eli Lilly and Co. announced Tuesday that it will spend up to $7.8 billion to acquire a United Kingdom-based pharmaceutical ...

Rademikibart administered as a single 300 mg 2-minute IV push to asthma and chronic obstructive pulmonary disease (COPD) patients produced rapid improvement in FEV1 with many patients experiencing imp ...